Skip to main content

Advertisement

SpringerLink
Log in

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: implication for vaccination regimens

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

References

  1. Ossenkoppele GJ, Stam AG, Westers TM, de Gruijl TD, Janssen JJ, van de Loosdrecht AA et al. Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells. Leukemia 2003; 17: 1424–1426.

    Article  CAS  Google Scholar 

  2. Bocchia M, Gentili S, Abruzzese E, Fanelli A, Iuliano F, Tabilio A et al. Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial. Lancet 2005; 365: 657–662.

    Article  CAS  Google Scholar 

  3. Westers TM, Houtenbos I, Snoijs NC, van de Loosdrecht AA, Ossenkoppele GJ . Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacity. Leukemia 2005; 19: 1270–1272.

    Article  CAS  Google Scholar 

  4. Lindner I, Kharfan-Dabaja MA, Ayala E, Kolonias D, Carlson LM, Beazer-Barclay Y et al. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J Immunol 2003; 171: 1780–1791.

    Article  CAS  Google Scholar 

  5. Cwynarski K, Laylor R, Macchiarulo E, Goldman J, Lombardi G, Melo JV et al. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia 2004; 18: 1332–1339.

    Article  CAS  Google Scholar 

  6. Seggewiss R, Lore K, Greiner E, Magnusson MK, Price DA, Douek DC et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 2005; 105: 2473–2479.

    Article  CAS  Google Scholar 

  7. Peng B, Hayes M, Resta D, Racine-Poon A, Druker BJ, Talpaz M et al. Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients. J Clin Oncol 2004; 22: 935–942.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Bijan Moshaver and Marjolein Klaver for technical assistance and Novartis for providing Imatinib mesylate and financial support.

Author information

Authors and Affiliations

  1. Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands

    T M Westers, J J W M Janssen, I Houtenbos, N C L Snoijs, A A van de Loosdrecht & G J Ossenkoppele

Authors
  1. T M Westers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J J W M Janssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Houtenbos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N C L Snoijs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A A van de Loosdrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G J Ossenkoppele
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T M Westers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westers, T., Janssen, J., Houtenbos, I. et al. Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: implication for vaccination regimens. Leukemia 20, 154–157 (2006). https://doi.org/10.1038/sj.leu.2404043

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404043

  • Springer Nature Limited

This article is cited by

Search

Navigation